INSYS Therapeutics Inc
0 DAYS LEFT TO SEEK LEAD PLAINTIFF STATUS
Case Summary | |
Company Name: | INSYS Therapeutics Inc |
Stock Symbol : | NASDAQ: INSY |
Class Period Start: | 03/03/2015 |
Class Period End: | 01/25/2016 |
Lead Plaintiff motion: | 04/04/2016 |
Date Filed: | 02/02/2016 |
Type of Case: | Securities Class Action |
Court: | U.S. District Court for the District of Arizona |
Summary: | Thieler Law Corp advises investors with losses exceeding $100,000 of the April 4, 2016 lead plaintiff deadline in a class action lawsuit filed against INSYS Therapeutics Inc (NASDAQ: INSY) (“INSYS Therapeutics” or “the Company”). The suit is pending in the U.S. District Court for the District of Arizona and investors, who purchased INSYS Therapeutics securities between March 3, 2015 through January 25, 2016 have until April 4, 2016 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class. If you purchased INSYS Therapeutics securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class. The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that INSYS Therapeutics was engaged in the illegal and improper off-labeling marketing of Subsys; certain INSYS Therapeutics employees were complicit in an illegal kickback scheme operated for the purpose of increasing prescriptions of Subsys; and as a result, the Company's financial statements were materially false and misleading at all relevant times. On January 25, 2016, an article was published entitled “The Brotherhood of Thieves: Insys Therapeutics,” claiming that INSYS Therapeutics pressured employees to develop new schemes to promote the illegal and improper off-label use and sale of Subsys. On this news, NASDAQ: INSY shares dropped causing investors harm. If you were negatively impacted by your investment in INSYS Therapeutics securities between March 3, 2015 through January 25, 2016 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation. Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Thieler Law Corp 2534 State Street - Suite 406, San Diego, CA 92101 by email: mail@thielerlaw.com or telephone at +1 (619) 377 - 4324 or visit our website http://www.thielerlaw.com/ or Facsimile: +1 (619) 785 – 3185 |